KalVista Pharmaceuticals
KALV
KALV
57 hedge funds and large institutions have $261M invested in KalVista Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.16% more ownership
Funds ownership: 73.12% → 77.28% (+4.2%)
6% less capital invested
Capital invested by funds: $278M → $261M (-$16.5M)
Holders
57
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$5.82M | |
| 2 | +$5.46M | |
| 3 | +$3.95M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
+$2.44M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$1.56M |
Top Sellers
| 1 | -$7.04M | |
| 2 | -$4.42M | |
| 3 | -$3.05M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.77M |
| 5 |
Millennium Management
New York
|
-$1.15M |